Co-fund health research
We co-fund health research and research facilities with partners such as charities, industry, trust funds and public funding bodies in areas of strategic priority and where the scope of the partner’s research complements our own funding streams.
Join Dementia Research
Join Dementia Research (JDR) is an initiative led by our Clinical Research Network in partnership with Alzheimer Scotland, Alzheimer's Research UK and Alzheimer's Society. It works to increase public awareness for dementia research and improve study recruitment, providing researchers with access to thousands of potential volunteers who want to be involved in research.
Any member of the public can register as a volunteer to get involved in supporting dementia studies. Researchers are also encouraged to identify potential participants, screen and contact volunteers and participate in feasibility studies. The JDR initiative has organised campaigns in the NHS in order to raise awareness amongst staff and help them engage with patients better.
Partnership with Cancer Research UK
We fund 14 Experimental Cancer Medicine Centres (ECMCs) across England in close partnership with Cancer Research UK. The ECMC network brings together early translational research in cancer biology with clinicians to speed up the process of cancer drug development and the search for cancer biomarkers.
Partnership with the Medical Research Council
The MRC-NIHR National Phenome Centre is co-funded with the Medical Research Council (MRC). It offers broad access to a world-class capability in metabolic phenotyping and a multidisciplinary team of specialists in biochemistry, the analytical platforms and informatics. It works with researchers as both an integrated collaborative research programme or on a fee-for-service basis depending on the researchers’ needs. The centre is led by Imperial College London and King's College London.
Partnering with industry
Our centres form strategic partnerships with industry to work on specific research areas and for the co-production of medical technology innovations and diagnostics. During the financial year 2015/16, our centres and facilities formed 1,378 collaborations with small and medium enterprises (SMEs) and 576 partnerships with industry, resulting in £149.7m of funding.
Collaboration of the NIHR with the MRC, GSK and five leading UK universities
In July 2015, the MRC, GlaxoSmithKline (GSK) and five leading UK universities formed a collaboration to study difficult disease areas.
The MRC and GSK collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases that present a serious burden to patients. The collaboration is supported by the NIHR Cambridge Biomedical Research Centre, the NIHR Newcastle Biomedical Research Centre, the NIHR Imperial Biomedical Research Centre and the NIHR University College London Hospitals Biomedical Research Centre.
The Experimental Medicine Initiative to Explore New Therapies (EMINENT) network will be coordinated by University College London (UCL) and will bring together teams of researchers from the Universities of Cambridge, Glasgow, Newcastle, Imperial College London and UCL, with GSK researchers to study the fundamental biological mechanisms responsible for a range of inflammatory diseases. It is hoped that combining the disease biology expertise of these academic scientists with GSK’s drug development expertise and resources will ultimately lead to breakthroughs in understanding that could accelerate the development of innovative treatments for patients.
Health Innovation Challenge Fund
The Health Innovation Challenge Fund (HIC) Fund is a strategic partnership between the Department of Health and the Wellcome Trust. The HIC Fund is a translational funding scheme to accelerate the development of a technology or intervention.
The HIC Fund and the NIHR Invention for Innovation (i4i) Programme complement each other at a key translational gap. The HIC Fund can start earlier in the developmental pathway, whereas i4i works to achieve a clinical impact in a shorter time frame, with delivery through and by the NHS.
To find out more, contact:
National Institute for Health Research
Central Commissioning Facility
15 Church Street
Tel: 020 8843 8000